Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$35.31 - $50.56 $24,717 - $35,392
-700 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$25.8 - $41.09 $18,060 - $28,763
700 New
700 $29,000
Q3 2020

Nov 16, 2020

SELL
$27.5 - $39.61 $825,000 - $1.19 Million
-30,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$36.1 - $42.56 $1.08 Million - $1.28 Million
30,000 New
30,000 $1.28 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.